Research Analysts’ Weekly Ratings Updates for McKesson (MCK)

McKesson (NYSE: MCK) recently received a number of ratings updates from brokerages and research firms:

• 2/5/2026 – McKesson was downgraded by analysts at Weiss Ratings from a “buy (a-)” rating to a “buy (b+)” rating.
• 2/5/2026 – McKesson had its price target raised by analysts at TD Cowen from $1,000.00 to $1,012.00. They now have a “buy” rating on the stock.
• 2/5/2026 – McKesson had its price target raised by analysts at Wells Fargo & Company from $914.00 to $925.00. They now have an “equal weight” rating on the stock.
• 2/5/2026 – McKesson had its price target raised by analysts at Mizuho from $880.00 to $885.00. They now have a “neutral” rating on the stock.
• 1/29/2026 – McKesson had its “overweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $966.00 price target on the stock.
• 1/14/2026 – McKesson was given a new $968.00 price target on by analysts at Robert W. Baird.
• 12/29/2025 – McKesson had its “buy (a-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – McKesson had its “buy (a-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – McKesson had its “buy” rating reaffirmed by analysts at TD Cowen.
• 12/15/2025 – McKesson had its “buy (a-)” rating reaffirmed by analysts at Weiss Ratings.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

Insider Buying and Selling

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Thomas L. Rodgers sold 276 shares of the business’s stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the sale, the executive vice president owned 2,268 shares in the company, valued at $1,851,096.24. This trade represents a 10.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.08% of the company’s stock.

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.